Sensus
1 known investors
Find your way into Sensus
Bough Bio develops therapies that target senescent cells in the brain to treat neurological and psychiatric diseases. The company focuses on clearing damaged cells to restore healthy brain function and address conditions related to stress-induced brain damage.
Founders & leadership
BK
Ben KolisnykinCEO
Investors · 1
In the news
Frequently asked questions
- What does Sensus do?
- Bough Bio develops therapies that target senescent cells in the brain to treat neurological and psychiatric diseases. The company focuses on clearing damaged cells to restore healthy brain function and address conditions related to stress-induced brain damage.
- Who are Sensus's investors?
- Sensus's investors include CABHI Ventures.